BioSpace News Archive

The surrogacy company, Joy of Life, based in Southern California, achieved major successes in 2018 and helped many families make their dream of fertility come true. Joy of Life took advantage of the growth of industry to improve the company’s business, hoping to bring more high-quality services to both intended parents and surrogates.

Path Defined to Submit for Accelerated Approval in All FL Patients after at least Two Prior Lines of Therapy Based on Fully Enrolled Phase 2 Study

SAGE Therapeutics announced that, on January 2, 2019, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 15,000 shares of its common stock to five new employees under Sage’s 2016 Inducement Equity Plan

Owens & Minor, Inc. will participate in the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Thursday, January 10, 2019, at 9:30 a.m. Pacific Time

Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions, today announced the closing of a $65 million Series B financing. P

Lead Candidate in Clinical Trial for Treating Ewing Sarcoma

Fiscal 2019 Second Quarter Highlights

Strategic acquisition provides national presence to accelerate growth across Canada

Top-line avapritinib data support planned NDA for PDGFRA Exon 18 mutant GIST and fourth-line GIST in first half 2019

Sangamo Therapeutics, Inc. announced that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9th at 11:30 a.m. PT in San Francisco